Integrated Biopharma Stock Performance

Integrated Biopharma Relative Risk vs. Return Landscape

If you would invest  30.00  in Integrated Biopharma on November 1, 2025 and sell it today you would earn a total of  0.00  from holding Integrated Biopharma or generate 0.0% return on investment over 90 days. Integrated Biopharma is currently generating 0.1083% in daily expected returns and assumes 4.7287% risk (volatility on return distribution) over the 90 days horizon. In different words, 42% of otc stocks are less volatile than Integrated, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Integrated Biopharma is expected to generate 6.29 times more return on investment than the market. However, the company is 6.29 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

Integrated Biopharma Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Integrated Biopharma has a beta of -0.25. This usually indicates as returns on the benchmark increase, returns on holding Integrated Biopharma are expected to decrease at a much lower rate. During a bear market, however, Integrated Biopharma is likely to outperform the market. Additionally Integrated Biopharma has an alpha of 0.0541, implying that it can generate a 0.0541 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Integrated Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Integrated Biopharma. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.02 0.30 5.03 Details

Intrinsic Valuation Low Real High 0.01 0.26 4.99 Details

Naive Forecast Low Next High 0.01 0.27 4.99 Details

Bollinger Band Projection (param) Lower Middle Band Upper 0.31 0.35 0.39 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Integrated Biopharma. Your research has to be compared to or analyzed against Integrated Biopharma's peers to derive any actionable benefits. When done correctly, Integrated Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Integrated Biopharma.

Integrated Biopharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Integrated Biopharma is not an exception. The market had few large corrections towards the Integrated Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Integrated Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Integrated Biopharma within the framework of very fundamental risk indicators.

Integrated Biopharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Integrated Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Integrated Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Integrated Biopharma Fundamentals Growth

When running Integrated Biopharma's price analysis, check to measure Integrated Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Biopharma is operating at the current time. Most of Integrated Biopharma's value examination focuses on studying past and present price action to predict the probability of Integrated Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Biopharma's price. Additionally, you may evaluate how the addition of Integrated Biopharma to your portfolios can decrease your overall portfolio volatility.